Cargando…

716. Effect of Carbapenem-resistant vs. Carbapenem-susceptible Enterobacterales infections on patient outcomes at an academic medical center

BACKGROUND: Carbapenem-resistant Enterobacterales (CRE) infections have been shown to lead to excess mortality in patients. To estimate the impact of CRE at an academic medical center not in an endemic area for CRE infections, we sought to compare them against patients having infections by carbapene...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Justin A, Burgess, David, Moga, Daniella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678463/
http://dx.doi.org/10.1093/ofid/ofad500.778
_version_ 1785150367659458560
author Clark, Justin A
Burgess, David
Moga, Daniella
author_facet Clark, Justin A
Burgess, David
Moga, Daniella
author_sort Clark, Justin A
collection PubMed
description BACKGROUND: Carbapenem-resistant Enterobacterales (CRE) infections have been shown to lead to excess mortality in patients. To estimate the impact of CRE at an academic medical center not in an endemic area for CRE infections, we sought to compare them against patients having infections by carbapenem-susceptible Enterobacterales (CSE). METHODS: This was a retrospective cohort study performed at UK Healthcare Medical Center which assessed admissions between January 1, 2010 – December 31, 2019. The index date was the first positive culture of E. coli, E. cloacae, K. aerogenes, K. oxytoca, and/or K. pneumoniae. Patients having a CRE culture on index were included in the exposure group, and those having all CSE cultures were included in the comparator group. Exclusion criteria were age < 18 years old, pregnancy, endocarditis, osteomyelitis, necrotizing fasciitis, or cystic fibrosis. Outcomes of interest were 14- and 30-day composite of all-cause mortality or discharge to hospice with follow-up beginning from the index culture. Relative risk (RR) and hazard ratio (HR) were utilized to compare outcomes and inverse probability of treatment weighting (IPTW) was used for statistical adjustment. RESULTS: Across the decade, 128 patients were included in the CRE group and 6,953 in the CSE group. IPTW-adjusted RR and HR [95% CI] of composite outcome were 1.11 [0.7, 1.74] and 0.98 [0.61, 1.57] after 14 days and 1.19 [0.8, 1.77] and 0.99 [0.65, 1.51] after 30 days, respectively. When utilizing an exposure definition of carbapenem non-susceptible Enterobacterales (CNSE), the RR and HR were 1.11 [0.79, 1.57] and 0.95 [0.66, 1.36] after 14 days and 1.25 [0.93, 1.68] and 1.02 [0.75, 1.4] after 30 days. When using the non-susceptible exposure and only including patients with bloodstream infections on index, the RR and HR were 1.50 [0.93, 2.43] and 1.42 [0.85, 2.36] after 14 days and 1.48 [0.96, 2.29] and 1.38 [0.85, 2.24] after 30 days. CONCLUSION: Although the composite outcomes between the CRE and CSE groups were not statistically significantly different, an increased risk appeared to exist in follow-up analysis. Continued efforts including observations across multiple institutions are needed to further characterize risks associated with CRE infections. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10678463
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106784632023-11-27 716. Effect of Carbapenem-resistant vs. Carbapenem-susceptible Enterobacterales infections on patient outcomes at an academic medical center Clark, Justin A Burgess, David Moga, Daniella Open Forum Infect Dis Abstract BACKGROUND: Carbapenem-resistant Enterobacterales (CRE) infections have been shown to lead to excess mortality in patients. To estimate the impact of CRE at an academic medical center not in an endemic area for CRE infections, we sought to compare them against patients having infections by carbapenem-susceptible Enterobacterales (CSE). METHODS: This was a retrospective cohort study performed at UK Healthcare Medical Center which assessed admissions between January 1, 2010 – December 31, 2019. The index date was the first positive culture of E. coli, E. cloacae, K. aerogenes, K. oxytoca, and/or K. pneumoniae. Patients having a CRE culture on index were included in the exposure group, and those having all CSE cultures were included in the comparator group. Exclusion criteria were age < 18 years old, pregnancy, endocarditis, osteomyelitis, necrotizing fasciitis, or cystic fibrosis. Outcomes of interest were 14- and 30-day composite of all-cause mortality or discharge to hospice with follow-up beginning from the index culture. Relative risk (RR) and hazard ratio (HR) were utilized to compare outcomes and inverse probability of treatment weighting (IPTW) was used for statistical adjustment. RESULTS: Across the decade, 128 patients were included in the CRE group and 6,953 in the CSE group. IPTW-adjusted RR and HR [95% CI] of composite outcome were 1.11 [0.7, 1.74] and 0.98 [0.61, 1.57] after 14 days and 1.19 [0.8, 1.77] and 0.99 [0.65, 1.51] after 30 days, respectively. When utilizing an exposure definition of carbapenem non-susceptible Enterobacterales (CNSE), the RR and HR were 1.11 [0.79, 1.57] and 0.95 [0.66, 1.36] after 14 days and 1.25 [0.93, 1.68] and 1.02 [0.75, 1.4] after 30 days. When using the non-susceptible exposure and only including patients with bloodstream infections on index, the RR and HR were 1.50 [0.93, 2.43] and 1.42 [0.85, 2.36] after 14 days and 1.48 [0.96, 2.29] and 1.38 [0.85, 2.24] after 30 days. CONCLUSION: Although the composite outcomes between the CRE and CSE groups were not statistically significantly different, an increased risk appeared to exist in follow-up analysis. Continued efforts including observations across multiple institutions are needed to further characterize risks associated with CRE infections. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10678463/ http://dx.doi.org/10.1093/ofid/ofad500.778 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Clark, Justin A
Burgess, David
Moga, Daniella
716. Effect of Carbapenem-resistant vs. Carbapenem-susceptible Enterobacterales infections on patient outcomes at an academic medical center
title 716. Effect of Carbapenem-resistant vs. Carbapenem-susceptible Enterobacterales infections on patient outcomes at an academic medical center
title_full 716. Effect of Carbapenem-resistant vs. Carbapenem-susceptible Enterobacterales infections on patient outcomes at an academic medical center
title_fullStr 716. Effect of Carbapenem-resistant vs. Carbapenem-susceptible Enterobacterales infections on patient outcomes at an academic medical center
title_full_unstemmed 716. Effect of Carbapenem-resistant vs. Carbapenem-susceptible Enterobacterales infections on patient outcomes at an academic medical center
title_short 716. Effect of Carbapenem-resistant vs. Carbapenem-susceptible Enterobacterales infections on patient outcomes at an academic medical center
title_sort 716. effect of carbapenem-resistant vs. carbapenem-susceptible enterobacterales infections on patient outcomes at an academic medical center
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678463/
http://dx.doi.org/10.1093/ofid/ofad500.778
work_keys_str_mv AT clarkjustina 716effectofcarbapenemresistantvscarbapenemsusceptibleenterobacteralesinfectionsonpatientoutcomesatanacademicmedicalcenter
AT burgessdavid 716effectofcarbapenemresistantvscarbapenemsusceptibleenterobacteralesinfectionsonpatientoutcomesatanacademicmedicalcenter
AT mogadaniella 716effectofcarbapenemresistantvscarbapenemsusceptibleenterobacteralesinfectionsonpatientoutcomesatanacademicmedicalcenter